M. Karck et al., MYOCARDIAL PROTECTION IN CHRONIC VOLUME-OVERLOAD HYPERTROPHY OF IMMATURE RAT HEARTS, European journal of cardio-thoracic surgery, 10(8), 1996, pp. 690-698
Objective. The benefit of cardioplegic cardiac arrest for protection o
f the immature myocardium is controversial. We therefore investigated
the efficacy of (1) topical hypothermia alone (2) slow cooling by coro
nary perfusion hypothermia and (3) cardioplegic cardiac arrest plus to
pical cooling for protection of isolated immature rat hearts (age: 28
days). Methods. The isolated perfused rat heart model was used. Hearts
were subjected to 8 h of global ischemia at 10 degrees C, The study w
as conducted after clinically relevant conditions of volume-overload m
yocardial hypertrophy had been established non-invasively by lifelong
feeding of a diet low in iron. Parameters of left ventricular function
, endothelial function, the metabolic status and myocardial injury wer
e measured. Results. Topical hypothermia provided superior protection
of hypertrophied hearts with recovery of maximum developed left ventri
cular pressure and rate of pressure rise at 41.2% +/- 22.3% and 34.5%
+/- 20.7% (mean +/- standard deviation) of preischemic values (P < 0.0
5 versus slow cooling and versus cardioplegia plus topical hypothermia
). The same pattern of recovery was observed among control hearts. The
recovery of endothelial function following protection by topical hypo
thermia alone measured 55% +/- 41% in hypertrophied hearts and 62% +/-
37% in control hearts, but was not recordable in all other groups. In
hypertrophied hearts post-ischemic myocardial high energy content was
significantly improved with topical hypothermia alone for protection
when compared to the other methods. Creatine kinase leakage during rep
erfusion did not differ significantly among the experimental groups. C
onclusion. Rapid cooling by topical hypothermia alonge provides superi
or protection of hypertrophied - and non-hypertrophied - immature rat
hearts to additional slow pre-arrest cooling. Use of St. Thomas' Hospi
tal cardioplegic solution No. 2 (STS 2) does not improve protection, a
nd even hinders functional recovery in hypertrophied immature hearts,
Endothelial injury caused by cold asanguinous perfusates, including ca
rdioplegia, interferes with the recovery of vascular function, which i
n turn, may limit mechanical function.